 | • レポートコード：GIR-105X14938 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、膣炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。膣炎治療薬の種類別市場規模（Rx、OTC）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・膣炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Pfizer、Sanofi、Piramal、Abbott、Galderma、Mission、Alkem、Xiuzheng、Teva、Perrigo、West-Ward、HPGC、Yunnan Baiyao、Starpharma、Novel、Edenvridge ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Rx、OTC ・用途別分析2016年-2026年：病院、薬局、その他 ・膣炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・膣炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・膣炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・膣炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・膣炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vaginosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vaginosis Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Vaginosis Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vaginosis Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rx
OTC
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Vaginosis Drug market are listed below:
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Vaginosis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaginosis Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rx
1.2.3 OTC
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaginosis Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Vaginosis Drug Market Size & Forecast
1.4.1 Global Vaginosis Drug Sales in Value (2016-2026))
1.4.2 Global Vaginosis Drug Sales in Volume (2016-2026)
1.4.3 Global Vaginosis Drug Price by Type (2016-2026) & (USD/Dose)
1.5 Global Vaginosis Drug Production Capacity Analysis
1.5.1 Global Vaginosis Drug Total Production Capacity (2016-2026)
1.5.2 Global Vaginosis Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaginosis Drug Market Drivers
1.6.2 Vaginosis Drug Market Restraints
1.6.3 Vaginosis Drug Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Vaginosis Drug Product and Services
2.1.4 Bayer Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Vaginosis Drug Product and Services
2.2.4 Pfizer Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Vaginosis Drug Product and Services
2.3.4 Sanofi Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Piramal
2.4.1 Piramal Details
2.4.2 Piramal Major Business
2.4.3 Piramal Vaginosis Drug Product and Services
2.4.4 Piramal Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Vaginosis Drug Product and Services
2.5.4 Abbott Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Galderma
2.6.1 Galderma Details
2.6.2 Galderma Major Business
2.6.3 Galderma Vaginosis Drug Product and Services
2.6.4 Galderma Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Mission
2.7.1 Mission Details
2.7.2 Mission Major Business
2.7.3 Mission Vaginosis Drug Product and Services
2.7.4 Mission Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Alkem
2.8.1 Alkem Details
2.8.2 Alkem Major Business
2.8.3 Alkem Vaginosis Drug Product and Services
2.8.4 Alkem Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Xiuzheng
2.9.1 Xiuzheng Details
2.9.2 Xiuzheng Major Business
2.9.3 Xiuzheng Vaginosis Drug Product and Services
2.9.4 Xiuzheng Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Vaginosis Drug Product and Services
2.10.4 Teva Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Perrigo
2.11.1 Perrigo Details
2.11.2 Perrigo Major Business
2.11.3 Perrigo Vaginosis Drug Product and Services
2.11.4 Perrigo Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 West-Ward
2.12.1 West-Ward Details
2.12.2 West-Ward Major Business
2.12.3 West-Ward Vaginosis Drug Product and Services
2.12.4 West-Ward Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 HPGC
2.13.1 HPGC Details
2.13.2 HPGC Major Business
2.13.3 HPGC Vaginosis Drug Product and Services
2.13.4 HPGC Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Yunnan Baiyao
2.14.1 Yunnan Baiyao Details
2.14.2 Yunnan Baiyao Major Business
2.14.3 Yunnan Baiyao Vaginosis Drug Product and Services
2.14.4 Yunnan Baiyao Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Starpharma
2.15.1 Starpharma Details
2.15.2 Starpharma Major Business
2.15.3 Starpharma Vaginosis Drug Product and Services
2.15.4 Starpharma Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Novel
2.16.1 Novel Details
2.16.2 Novel Major Business
2.16.3 Novel Vaginosis Drug Product and Services
2.16.4 Novel Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Edenvridge
2.17.1 Edenvridge Details
2.17.2 Edenvridge Major Business
2.17.3 Edenvridge Vaginosis Drug Product and Services
2.17.4 Edenvridge Vaginosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Vaginosis Drug Sales by Manufacturer
3.1 Global Vaginosis Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vaginosis Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vaginosis Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Vaginosis Drug Manufacturer Market Share
3.4.2 Top 6 Vaginosis Drug Manufacturer Market Share
3.5 Global Vaginosis Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vaginosis Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vaginosis Drug Market Size by Region
4.1.1 Global Vaginosis Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Vaginosis Drug Revenue by Region (2016-2026)
4.2 North America Vaginosis Drug Revenue (2016-2026)
4.3 Europe Vaginosis Drug Revenue (2016-2026)
4.4 Asia-Pacific Vaginosis Drug Revenue (2016-2026)
4.5 South America Vaginosis Drug Revenue (2016-2026)
4.6 Middle East and Africa Vaginosis Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vaginosis Drug Sales in Volume by Type (2016-2026)
5.2 Global Vaginosis Drug Revenue by Type (2016-2026)
5.3 Global Vaginosis Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vaginosis Drug Sales in Volume by Application (2016-2026)
6.2 Global Vaginosis Drug Revenue by Application (2016-2026)
6.3 Global Vaginosis Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vaginosis Drug Sales by Type (2016-2026)
7.2 North America Vaginosis Drug Sales by Application (2016-2026)
7.3 North America Vaginosis Drug Market Size by Country
7.3.1 North America Vaginosis Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Vaginosis Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vaginosis Drug Sales by Type (2016-2026)
8.2 Europe Vaginosis Drug Sales by Application (2016-2026)
8.3 Europe Vaginosis Drug Market Size by Country
8.3.1 Europe Vaginosis Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Vaginosis Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vaginosis Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Vaginosis Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Vaginosis Drug Market Size by Region
9.3.1 Asia-Pacific Vaginosis Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vaginosis Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vaginosis Drug Sales by Type (2016-2026)
10.2 South America Vaginosis Drug Sales by Application (2016-2026)
10.3 South America Vaginosis Drug Market Size by Country
10.3.1 South America Vaginosis Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Vaginosis Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vaginosis Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Vaginosis Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Vaginosis Drug Market Size by Country
11.3.1 Middle East & Africa Vaginosis Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vaginosis Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vaginosis Drug Typical Distributors
12.3 Vaginosis Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vaginosis Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vaginosis Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Vaginosis Drug Product and Services
Table 6. Bayer Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Vaginosis Drug Product and Services
Table 10. Pfizer Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Vaginosis Drug Product and Services
Table 14. Sanofi Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Piramal Basic Information, Manufacturing Base and Competitors
Table 16. Piramal Major Business
Table 17. Piramal Vaginosis Drug Product and Services
Table 18. Piramal Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Abbott Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Major Business
Table 21. Abbott Vaginosis Drug Product and Services
Table 22. Abbott Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Galderma Basic Information, Manufacturing Base and Competitors
Table 24. Galderma Major Business
Table 25. Galderma Vaginosis Drug Product and Services
Table 26. Galderma Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mission Basic Information, Manufacturing Base and Competitors
Table 28. Mission Major Business
Table 29. Mission Vaginosis Drug Product and Services
Table 30. Mission Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Alkem Basic Information, Manufacturing Base and Competitors
Table 32. Alkem Major Business
Table 33. Alkem Vaginosis Drug Product and Services
Table 34. Alkem Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Xiuzheng Basic Information, Manufacturing Base and Competitors
Table 36. Xiuzheng Major Business
Table 37. Xiuzheng Vaginosis Drug Product and Services
Table 38. Xiuzheng Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Teva Basic Information, Manufacturing Base and Competitors
Table 40. Teva Major Business
Table 41. Teva Vaginosis Drug Product and Services
Table 42. Teva Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Perrigo Basic Information, Manufacturing Base and Competitors
Table 44. Perrigo Major Business
Table 45. Perrigo Vaginosis Drug Product and Services
Table 46. Perrigo Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. West-Ward Basic Information, Manufacturing Base and Competitors
Table 48. West-Ward Major Business
Table 49. West-Ward Vaginosis Drug Product and Services
Table 50. West-Ward Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. HPGC Basic Information, Manufacturing Base and Competitors
Table 52. HPGC Major Business
Table 53. HPGC Vaginosis Drug Product and Services
Table 54. HPGC Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Yunnan Baiyao Basic Information, Manufacturing Base and Competitors
Table 56. Yunnan Baiyao Major Business
Table 57. Yunnan Baiyao Vaginosis Drug Product and Services
Table 58. Yunnan Baiyao Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Starpharma Basic Information, Manufacturing Base and Competitors
Table 60. Starpharma Major Business
Table 61. Starpharma Vaginosis Drug Product and Services
Table 62. Starpharma Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Novel Basic Information, Manufacturing Base and Competitors
Table 64. Novel Major Business
Table 65. Novel Vaginosis Drug Product and Services
Table 66. Novel Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Edenvridge Basic Information, Manufacturing Base and Competitors
Table 68. Edenvridge Major Business
Table 69. Edenvridge Vaginosis Drug Product and Services
Table 70. Edenvridge Vaginosis Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Vaginosis Drug Sales by Manufacturer (2019-2021e) & (K Doses)
Table 72. Global Vaginosis Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Vaginosis Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Vaginosis Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 75. Head Office and Vaginosis Drug Production Site of Key Manufacturer
Table 76. Global Vaginosis Drug Sales by Region (2016-2021e) & (K Doses)
Table 77. Global Vaginosis Drug Sales by Region (2021-2026) & (K Doses)
Table 78. Global Vaginosis Drug Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global Vaginosis Drug Revenue by Region (2021-2026) & (USD Million)
Table 80. Global Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 81. Global Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 82. Global Vaginosis Drug Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global Vaginosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 84. Global Vaginosis Drug Price by Type (2016-2021e) & (USD/Dose)
Table 85. Global Vaginosis Drug Price by Type (2021-2026) & (USD/Dose)
Table 86. Global Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 87. Global Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 88. Global Vaginosis Drug Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global Vaginosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 90. Global Vaginosis Drug Price by Application (2016-2021e) & (USD/Dose)
Table 91. Global Vaginosis Drug Price by Application (2021-2026) & (USD/Dose)
Table 92. North America Vaginosis Drug Sales by Country (2016-2021e) & (K Doses)
Table 93. North America Vaginosis Drug Sales by Country (2021-2026) & (K Doses)
Table 94. North America Vaginosis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America Vaginosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. North America Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 97. North America Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 98. North America Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 99. North America Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 100. Europe Vaginosis Drug Sales by Country (2016-2021e) & (K Doses)
Table 101. Europe Vaginosis Drug Sales by Country (2021-2026) & (K Doses)
Table 102. Europe Vaginosis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe Vaginosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 105. Europe Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 106. Europe Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 107. Europe Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 108. Asia-Pacific Vaginosis Drug Sales by Region (2016-2021e) & (K Doses)
Table 109. Asia-Pacific Vaginosis Drug Sales by Region (2021-2026) & (K Doses)
Table 110. Asia-Pacific Vaginosis Drug Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific Vaginosis Drug Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 113. Asia-Pacific Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 114. Asia-Pacific Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 115. Asia-Pacific Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 116. South America Vaginosis Drug Sales by Country (2016-2021e) & (K Doses)
Table 117. South America Vaginosis Drug Sales by Country (2021-2026) & (K Doses)
Table 118. South America Vaginosis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America Vaginosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 120. South America Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 121. South America Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 122. South America Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 123. South America Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 124. Middle East & Africa Vaginosis Drug Sales by Country (2016-2021e) & (K Doses)
Table 125. Middle East & Africa Vaginosis Drug Sales by Country (2021-2026) & (K Doses)
Table 126. Middle East & Africa Vaginosis Drug Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa Vaginosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa Vaginosis Drug Sales by Type (2016-2021e) & (K Doses)
Table 129. Middle East & Africa Vaginosis Drug Sales by Type (2021-2026) & (K Doses)
Table 130. Middle East & Africa Vaginosis Drug Sales by Application (2016-2021e) & (K Doses)
Table 131. Middle East & Africa Vaginosis Drug Sales by Application (2021-2026) & (K Doses)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Vaginosis Drug Typical Distributors
Table 135. Vaginosis Drug Typical Customers
List of Figures
Figure 1. Vaginosis Drug Picture
Figure 2. Global Vaginosis Drug Sales Market Share by Type in 2020
Figure 3. Rx
Figure 4. OTC
Figure 5. Global Vaginosis Drug Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Other
Figure 9. Global Vaginosis Drug Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 10. Global Vaginosis Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Vaginosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Vaginosis Drug Sales (2016-2026) & (K Doses)
Figure 31. Global Vaginosis Drug Production Capacity (2016-2026) & (K Doses)
Figure 32. Global Vaginosis Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Vaginosis Drug Market Drivers
Figure 34. Vaginosis Drug Market Restraints
Figure 35. Vaginosis Drug Market Trends
Figure 36. Global Vaginosis Drug Sales Market Share by Manufacturer in 2020
Figure 37. Global Vaginosis Drug Revenue Market Share by Manufacturer in 2020
Figure 38. Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Vaginosis Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Vaginosis Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Vaginosis Drug Sales Market Share by Region (2016-2026)
Figure 42. Global Vaginosis Drug Revenue Market Share by Region (2016-2026)
Figure 43. North America Vaginosis Drug Revenue (2016-2026) & (USD Million)
Figure 44. Europe Vaginosis Drug Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Vaginosis Drug Revenue (2016-2026) & (USD Million)
Figure 46. South America Vaginosis Drug Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Vaginosis Drug Revenue (2016-2026) & (USD Million)
Figure 48. Global Vaginosis Drug Sales Market Share by Type (2016-2026)
Figure 49. Global Vaginosis Drug Revenue Market Share by Type (2016-2026)
Figure 50. Global Vaginosis Drug Price by Type (2016-2026) & (USD/Dose)
Figure 51. Global Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 52. Global Vaginosis Drug Revenue Market Share by Application (2016-2026)
Figure 53. Global Vaginosis Drug Price by Application (2016-2026) & (USD/Dose)
Figure 54. North America Vaginosis Drug Sales Market Share by Country (2016-2026)
Figure 55. North America Vaginosis Drug Revenue Market Share by Country (2016-2026)
Figure 56. North America Vaginosis Drug Sales Market Share by Type (2016-2026)
Figure 57. North America Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Vaginosis Drug Sales Market Share by Country (2016-2026)
Figure 59. Europe Vaginosis Drug Revenue Market Share by Country (2016-2026)
Figure 60. Europe Vaginosis Drug Sales Market Share by Type (2016-2026)
Figure 61. Europe Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Vaginosis Drug Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Vaginosis Drug Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Vaginosis Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Vaginosis Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Vaginosis Drug Revenue Market Share by Country (2016-2026)
Figure 68. South America Vaginosis Drug Sales Market Share by Type (2016-2026)
Figure 69. South America Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Vaginosis Drug Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Vaginosis Drug Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Vaginosis Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Vaginosis Drug Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
膣症迅速検査の世界市場2018-2025 Vaginosis is a defined as the changing conditions of the vagina. Bacterial vaginosis is an abnormal overgrowth of normal bacteria in the vagina and causes vaginal smelly discharge.The increasing prevalence of most common vaginal and sexually transmitted infection worldwide is expected to propel the …- 世界の予防的HIV治療薬市場 2021：企業別、地域別、種類・用途別 The Prophylactic HIV Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の抗エイズ薬市場 2021：企業別、地域別、種類・用途別 The Anti-AIDs Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- ナタリズマブ薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…